Long Shortz: Lung cancer trial edges closer to patient enrolment
Host Tylah Tully sits down with Racura Oncology CEO Dr Daniel Tillett to discuss the company’s upcoming HARNESS-1 lung cancer trial. Watch the video here.
0
likes
•
0
questions
•
0
company answers
Ask a question
Your question will be sent privately to Racura Oncology. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Racura Oncology a question about this update.